Analyze Diet
Journal of veterinary pharmacology and therapeutics1993; 16(3); 359-368; doi: 10.1111/j.1365-2885.1993.tb00183.x

Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse.

Abstract: The pharmacokinetics and pharmacological efficacy of orally (p.o.) administered acepromazine were studied and compared with the intravenous (i.v.) route of administration in a cross-over study using six horses. The oral kinetics of acepromazine can be described by a two-compartment open model with first-order absorption. The drug was rapidly absorbed after p.o. administration with a half-life of 0.84 h, tmax of 0.4 h and Cmax of 59 ng/ml. The elimination was slower after p.o. administration (half-life 6.04 h) than after i.v. injection (half-life 2.6 h). The bioavailability of the orally administered drug formulation was 55.1%. After p.o. administration of 0.5 mg/kg acepromazine, the parameters of the sedative effect were similar to those obtained after i.v. injection of 0.1 mg/kg. The effect of the drug on blood cell count and haemoglobin content was similar after both p.o. administration and injection, while the effects on the parameters of penile prolapse and on the mean arterial blood pressure were less pronounced after p.o. administration than after injection. After p.o. administration, no significant effects on haematocrit-level as well as on the heart and respiratory rates were observed, while these parameters were significantly affected after injection. It is concluded that the high initial plasma level of the drug after i.v. injection may play a role in producing adverse effects of acepromazine.
Publication Date: 1993-09-01 PubMed ID: 8230407DOI: 10.1111/j.1365-2885.1993.tb00183.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examined how efficiently the drug acepromazine, used as a sedative for horses, is absorbed and functions when given orally in comparison to intravenous administration. The findings indicated that the drug’s absorption and elimination rates differed between the two methods of administration, and side effects were less pronounced with oral administration.

Objective and Methodology

  • The primary objective of the research was to compare the efficiency of orally administered acepromazine (a widely used sedative in equine patients) to its intravenous administration.
  • This was achieved by studying the pharmacokinetics – how the drug is absorbed, distributed, metabolized, and excreted in the body – and pharmacological efficacy, which assesses the therapeutic effects of the drug.
  • Six horses were used in a cross-over study design, a type of longitudinal study in which subjects receive a sequence of different treatments. This facilitates direct comparison of different treatments administered to the same individual.

Findings

  • Acepromazine, when given orally, was rapidly absorbed into the body with a half-life of 0.84 hours, reaching its maximum concentration (Cmax) of 59 ng/ml at about 0.4 hours (tmax) after administration.
  • The rate at which the drug was eliminated from the body was slower for oral administration (half-life 6.04 hours) compared to intravenous administration (half-life 2.6 hours).
  • The oral bioavailability – the proportion of the drug that enters the circulation when introduced orally and so can have an active effect – was 55.1%. This implies that nearly half the drug might be lost during the digestion process, reducing the overall efficacy of the drug when administered orally.

Sedative Effect and Side Effects

  • After administration of 0.5 mg/kg acepromazine orally, the parameters of sedative effect were similar to those obtained after intravenous injection of 0.1 mg/kg.
  • The effects on blood count and haemoglobin content, an indication of oxygen-carrying capacity in the blood, were comparable for both oral administration and intravenous injection.
  • Effects on penile prolapse (a common side effect of acepromazine in males) and mean arterial blood pressure were less pronounced after oral administration compared to injection.
  • No significant effects on haematocrit level (percentage of red blood cells in blood), heart rate, and respiratory rates were observed after oral administration, whereas these parameters were significantly affected after injection.
  • This suggests that oral administration of acepromazine can minimize potential adverse side effects that may occur from intravenous administration.

Conclusion

  • The researchers concluded that the more immediate and concentrated introduction of the drug to the bloodstream via intravenous injection might lead to higher initial plasma levels, potentially causing more pronounced side effects. Hence, oral administration could be a safer, although slightly less efficient, alternative for sedation in horses.

Cite This Article

APA
Hashem A, Keller H. (1993). Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. J Vet Pharmacol Ther, 16(3), 359-368. https://doi.org/10.1111/j.1365-2885.1993.tb00183.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 16
Issue: 3
Pages: 359-368

Researcher Affiliations

Hashem, A
  • Department of Pharmacology and Toxicology, School of Veterinary Medicine, Free University of Berlin, Germany.
Keller, H

    MeSH Terms

    • Absorption
    • Acepromazine / administration & dosage
    • Acepromazine / pharmacokinetics
    • Acepromazine / pharmacology
    • Administration, Oral
    • Analgesia / veterinary
    • Animals
    • Biological Availability
    • Chromatography, High Pressure Liquid / veterinary
    • Female
    • Gels
    • Half-Life
    • Hemodynamics / drug effects
    • Horses / metabolism
    • Injections, Intravenous / veterinary
    • Male

    Citations

    This article has been cited 3 times.
    1. Kandeel M, Almubarak AI, Hussen J, El-Deeb W, Venugopala KN. Pharmacokinetic, Clinical, and Myeloid Marker Responses to Acepromazine Sedation in Arabian Camels. Front Vet Sci 2021;8:725841.
      doi: 10.3389/fvets.2021.725841pubmed: 34568476google scholar: lookup
    2. Joo YS, Lee HJ, Choi JS, Sung KW. Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells. Korean J Physiol Pharmacol 2017 Jan;21(1):75-82.
      doi: 10.4196/kjpp.2017.21.1.75pubmed: 28066143google scholar: lookup
    3. Erickson RL, Terzi MC, Jaber SM, Hankenson FC, McKinstry-Wu A, Kelz MB, Marx JO. Intraperitoneal Continuous-Rate Infusion for the Maintenance of Anesthesia in Laboratory Mice (Mus musculus). J Am Assoc Lab Anim Sci 2016;55(5):548-57.
      pubmed: 27657709